Continuous infusion metoclopramide: clinical trials, pharmacokinetic considerations and cost-effectiveness
Parashos, P.J.; Dugan, W.M.; Fry, M.W.
Progress in Clinical and Biological Research 248: 303-311
1987
ISSN/ISBN: 0361-7742 PMID: 3118389 Document Number: 298153
Document emailed within 1 workday
Related Documents
Agostinucci, W.A.; Gannon, R.H.; Golub, G.R.; Martin, R.S.; Schauer, P.K.; Dinonno, E.B. 1988: Continuous i.v. infusion versus multiple bolus doses of metoclopramide for prevention of cisplatin-induced emesis Clinical Pharmacy 7(6): 454-457Passe, P.; Delepine, N.; Arnaud, P.; Urien, S.; Delepine, G.; Traoré, F.; Desbois, J.C.; Brion, F. 1999: Pharmacokinetic modelling of ifosfamide administered by continuous infusion on 5 days at the dose of 6 g/m2 Anticancer Research 19(1B): 837-842
Walsh, T.J.; Lee, J.W.; Bacher, J.; Kelly, P.; Pizzo, P.A. 1992: Continuous intravenous infusion and simultaneous pharmacokinetic monitoring in ambulatory rabbits with a programmable micropump and dual subcutaneous Silastic central venous catheters Laboratory Animal Science 42(3): 286-292
Cristalli, A.; Taglione, G.C.; Prosperi, M.; Amici, O.; Mazza, E. 1995: Effectiveness and modality of continuous infusion administration of atracurium dibesylate Minerva Anestesiologica 61(3): 83-86
Hiejima, I.; Kumada, T.; Nozaki, F.; Hayasi, A.; Miyajima, T.; Fujii, T. 2015: Effectiveness of continuous infusion of tizanidine (Ternelin) via a feeding tube for patients with the mixed type of tetraplegia No to Hattatsu 47(1): 28-31
Marseille, E.; Giganti, M.J.; Mwango, A.; Chisembele-Taylor, A.; Mulenga, L.; Over, M.; Kahn, J.G.; Stringer, J.S.A. 2012: Taking ART to scale: determinants of the cost and cost-effectiveness of antiretroviral therapy in 45 clinical sites in Zambia Plos one 7(12): E51993
Bassett, I.V.; Govindasamy, D.; Erlwanger, A.S.; Hyle, E.P.; Kranzer, K.; van Schaik, N.; Noubary, F.; Paltiel, A.D.; Wood, R.; Walensky, R.P.; Losina, E.; Bekker, L.-G.; Freedberg, K.A. 2014: Mobile HIV screening in Cape Town, South Africa: clinical impact, cost and cost-effectiveness Plos one 9(1): E85197
Mitsuhata, H.; Matsumoto, S.; Hasegawa, J.; Ohtaka, K. 1991: Continuous intravenous pethidine infusion for analgesia after upper abdominal surgery: a randomized, prospective double-blind comparison with continuous epidural infusion of pethidine Masui. Japanese Journal of Anesthesiology 40(12): 1770-1776
Itano, S.; Hirai, K.; Kajiwara, M.; Ijuin, H.; Yoshiyama, Y.; Yoshida, T.; Sakata, K.; Ono, N.; Noguchi, H.; Sakai, T. 1994: A study of the drug distribution on intra-hepatic arterial infusion chemotherapy; how much difference between continuous infusion and rapid infusion? Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(13): 2136-2139
Taguchi, Y.; Yoshimoto, H.; Ikeda, S. 2016: Considerations of screening and brief intervention among high-risk drinkers in Japan: from the perspectives of feasibility and cost-effectiveness Nihon Arukoru Yakubutsu Igakkai Zasshi 51(1): 13-25
Thurgar, E.; Barton, S.; Karner, C.; Edwards, S.J. 2016: Clinical effectiveness and cost-effectiveness of interventions for the treatment of anogenital warts: systematic review and economic evaluation Health Technology Assessment 20(24): V-Vi 1-486
LeWitt, P.A. 1992: Clinical studies with and pharmacokinetic considerations of sustained-release levodopa Neurology 42(1 Suppl 1: 29-32; Discussion: 57-60
Splett, P.L. 1991: Phase I: status report of existing data on the effectiveness, cost, and cost effectiveness of nutrition care services Journal of the American Dietetic Association Suppl: S9-14
Splett, P.L. 1991: Phase I: status report of existing data on the effectiveness, cost, and cost effectiveness of nutrition care services Journal of the American Dietetic Association Suppl: S9-14
Faggioli, M. 1978: Erythromycin combined with balsamic agents in oral and rectal administration: results in pharmacokinetic and clinical trials La Clinica Terapeutica 84(2): 141-150
Lu, K.; Yap, H.Y.; Loo, T.L. 1983: Clinical pharmacokinetics of vinblastine by continuous intravenous infusion Cancer Research 43(3): 1405-1408
Volkers, P. 2006: Clinical trials with allergen products--statistical considerations Arbeiten aus dem Paul-Ehrlich-Institut Zu Frankfurt A.M 95: 172-180; Discussion 181
Brotons, C.; Moral, I.; Antón, J.J.; Cobos, M.; Cucurull, E.; Gállego, C.; Ibáñez, M.; Pérez, A.; Llussà, J.; Orozco, P.; Ventureira, S.; Samarra, M.; Sanz, J.; Permanyer, G.; López, A. 1997: Preventive treatment of nonrheumatic atrial fibrillation: from the efficacy of clinical trials to the effectiveness of clinical practice Atencion Primaria 20(7): 367-371
Garnick, M.B.; Weiss, G.R.; Steele, G.D.; Israel, M.; Schade, D.; Sack, M.J.; Frei, E. 1983: Clinical evaluation of long-term, continuous-infusion doxorubicin Cancer Treatment Reports 67(2): 133-142
Sylvester, R.; Collette, L. 1999: Statistical considerations of chemoprevention clinical trials in prostate cancer European Urology 35(5-6): 519-522